Literature DB >> 33077688

MANAGEMENT OF ENDOCRINE DISEASE: The role of surgical adrenalectomy in primary aldosteronism.

Gregory L Hundemer1, Anand Vaidya2.   

Abstract

Primary aldosteronism is common and contributes to adverse cardiovascular, kidney, and metabolic outcomes. When instituted early and effectively, targeted therapies can mitigate these adverse outcomes. Surgical adrenalectomy is among the most effective treatments because it has the potential to cure, or attenuate the severity of, pathologic aldosterone excess, resulting in a host of biochemical and clinical changes that improve health outcomes. Herein, we review the role of surgical adrenalectomy in primary aldosteronism while emphasizing the physiologic ramifications of surgical intervention, and compare these to other targeted medical therapies for primary aldosteronism. We specifically review the role of curative adrenalectomy for unilateral primary aldosteronism, the role of non-curative adrenalectomy for bilateral primary aldosteronism, and how these interventions influence biochemical and clinical outcomes in relation to medical therapies for primary aldosteronism.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33077688      PMCID: PMC7853245          DOI: 10.1530/EJE-20-0863

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  86 in total

1.  Left ventricular changes in primary aldosteronism.

Authors:  Gian Paolo Rossi; Maurizio Cesari; Achille C Pessina
Journal:  Am J Hypertens       Date:  2003-01       Impact factor: 2.689

2.  Increased prevalence of diabetes mellitus and the metabolic syndrome in patients with primary aldosteronism of the German Conn's Registry.

Authors:  Gregor Hanslik; Henri Wallaschofski; Anna Dietz; Anna Riester; Martin Reincke; Bruno Allolio; Katharina Lang; Ivo Quack; Lars C Rump; Holger S Willenberg; Felix Beuschlein; Marcus Quinkler; Anke Hannemann
Journal:  Eur J Endocrinol       Date:  2015-08-26       Impact factor: 6.664

3.  Adrenal Insufficiency After Unilateral Adrenalectomy in Primary Aldosteronism: Long-Term Outcome and Clinical Impact.

Authors:  Daniel A Heinrich; Christian Adolf; Finn Holler; Benjamin Lechner; Holger Schneider; Anna Riester; Nina Nirschl; Lisa Sturm; Xiao Wang; Roland Ladurner; Max Seidensticker; Martin Bidlingmaier; Felix Beuschlein; Martin Reincke
Journal:  J Clin Endocrinol Metab       Date:  2019-11-01       Impact factor: 5.958

Review 4.  Epithelial sodium transport and its control by aldosterone: the story of our internal environment revisited.

Authors:  Bernard C Rossier; Michael E Baker; Romain A Studer
Journal:  Physiol Rev       Date:  2015-01       Impact factor: 37.312

Review 5.  THERAPY OF ENDOCRINE DISEASE: Medical treatment of primary aldosteronism.

Authors:  Benjamin Lechner; Katharina Lechner; Daniel Alexander Heinrich; Christian Adolf; Finn Holler; Holger Schneider; Felix Beuschlein; Martin Reincke
Journal:  Eur J Endocrinol       Date:  2019-07-01       Impact factor: 6.664

6.  Accuracy of CT scanning and adrenal vein sampling in the pre-operative localization of aldosterone-secreting adrenal adenomas.

Authors:  R Harper; C G Ferrett; J A McKnight; E M McIlrath; C F Russell; B Sheridan; A B Atkinson
Journal:  QJM       Date:  1999-11

7.  The impact of Connshing's syndrome - mild cortisol excess in primary aldosteronism drives diabetes risk.

Authors:  Felix Beuschlein; Martin Reincke; Wiebke Arlt
Journal:  J Hypertens       Date:  2017-12       Impact factor: 4.844

8.  Relative glomerular hyperfiltration in primary aldosteronism.

Authors:  Jean Ribstein; Guilhem Du Cailar; Pierre Fesler; Albert Mimran
Journal:  J Am Soc Nephrol       Date:  2005-03-30       Impact factor: 10.121

9.  Role of unilateral adrenalectomy in bilateral primary aldosteronism: a 22-year single center experience.

Authors:  Norlela Sukor; Richard D Gordon; Yee Kim Ku; Mark Jones; Michael Stowasser
Journal:  J Clin Endocrinol Metab       Date:  2009-04-28       Impact factor: 5.958

10.  Cardiovascular complications associated with primary aldosteronism: a controlled cross-sectional study.

Authors:  Sébastien Savard; Laurence Amar; Pierre-François Plouin; Olivier Steichen
Journal:  Hypertension       Date:  2013-06-10       Impact factor: 10.190

View more
  4 in total

1.  Bilateral Adrenalectomy in a Patient With Refractory Primary Aldosteronism Due to Adrenal Hyperplasia.

Authors:  Luis Marín-Martínez; Antonio J Ríos-Vergara; Georgios Kyriakos; Maria C Álvarez-Martín; Enrique Hernández-Alonso
Journal:  Cureus       Date:  2022-04-19

Review 2.  Adrenocorticotropic Hormone-Stimulated Adrenal Venous Sampling Underestimates Surgically Curable Primary Aldosteronism: A Retrospective Cohort Study and Review of Contemporary Studies.

Authors:  Nicholas Yozamp; Gregory L Hundemer; Marwan Moussa; Jonathan Underhill; Tali Fudim; Barry Sacks; Anand Vaidya
Journal:  Hypertension       Date:  2021-05-17       Impact factor: 9.897

3.  Surgical Quality, Antihypertensive Therapy, and Electrolyte Balance: A Novel Trifecta to Assess Long-Term Outcomes of Adrenal Surgery for Unilateral Primary Aldosteronism.

Authors:  Umberto Anceschi; Marilda Mormando; Cristian Fiori; Orazio Zappalà; Bernardino De Concilio; Aldo Brassetti; Alessandro Carrara; Maria Consiglia Ferriero; Gabriele Tuderti; Leonardo Misuraca; Alfredo Maria Bove; Riccardo Mastroianni; Alfonsina Chiefari; Marialuisa Appetecchia; Giuseppe Tirone; Francesco Porpiglia; Antonio Celia; Michele Gallucci; Giuseppe Simone
Journal:  J Clin Med       Date:  2022-02-01       Impact factor: 4.241

4.  Validation of three novel clinical prediction tools for primary aldosteronism subtyping.

Authors:  Tomaž Kocjan; Gaj Vidmar; Peter Popović; Milenko Stanković
Journal:  Endocr Connect       Date:  2022-05-11       Impact factor: 3.221

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.